Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.21.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Consolidated net revenue $ 15,271 $ 1,888  
Consolidated cost of revenue 6,344 1,473  
Total Depreciation and amortization expense 348 5  
Operating and other expenses 7,522 1,219  
Total income (loss) from continuing operations, before income taxes 1,057 (809)  
Net income (loss) 1,057 (809)  
Total assets 85,444   $ 31,405
Diagnostic Services [Member]      
Consolidated net revenue 12,737  
Consolidated cost of revenue 4,345  
Total Depreciation and amortization expense 345  
Total income (loss) from continuing operations, before income taxes 2,839  
Total assets 40,349   13,410
Consumer Products [Member]      
Consolidated net revenue 2,534 1,888  
Consolidated cost of revenue 1,999 1,473  
Total Depreciation and amortization expense 3 5  
Total income (loss) from continuing operations, before income taxes (35) 410  
Total assets 5,589   6,261
Unallocated Corporate [Member]      
Total income (loss) from continuing operations, before income taxes (1,748) $ (1,219)  
Total assets $ 39,506   $ 11,734